Injectable testosterone works by replacing what the testes no longer produce enough of. The tradeoff is pituitary suppression: LH and FSH fall, the testes receive less stimulation, intratesticular testosterone collapses, and testicular volume shrinks. For men who care about fertility, aesthetics, or long-term axis recovery, human chorionic gonadotropin (hCG) is the most established adjunct to mitigate those effects.
hCG is a glycoprotein hormone produced by the placenta during pregnancy. In men, it binds LH receptors on Leydig cells and stimulates testosterone synthesis inside the testis, the same receptor LH uses, which is why hCG is called an LH mimic. It does not replace FSH for spermatogenesis directly, but restoring intratesticular testosterone is a prerequisite for sperm production.
The intratesticular testosterone problem
Serum testosterone on TRT can look excellent while the testes themselves are dormant. Intratesticular testosterone concentrations required for spermatogenesis are roughly 100-fold higher than serum levels. Exogenous testosterone saturates negative feedback at the hypothalamus and pituitary, so endogenous LH production stops and the local testicular environment cannot support robust sperm development.
This is why fertility clinics tell men to stop TRT months before attempting conception. hCG offers a pathway to maintain some intratesticular stimulation without discontinuing exogenous testosterone entirely, though outcomes vary and it is not as reliable as enclomiphene-first strategies for men whose primary goal is conception.
Common dosing protocols
Telehealth and urology protocols typically use:
- 500 IU subcutaneous two to three times per week alongside weekly testosterone
- 1,000 IU subcutaneous twice weekly for men with more significant atrophy or fertility goals
- 10,000 IU vials reconstituted and dosed in insulin syringes, the standard pharmacy SKU in men's health compounding menus
hCG is supplied as a lyophilized powder requiring bacteriostatic water reconstitution. Once mixed, vials have limited refrigerated stability (often 30 to 60 days depending on pharmacy guidance). Patients must understand reconstitution math and storage or adherence fails.
What hCG accomplishes on TRT
- Testicular volume maintenance. Men report less shrinkage when hCG is co-administered; objective ultrasound studies show partial preservation of testicular size.
- Partial fertility preservation. Some men maintain sperm in the ejaculate on TRT plus hCG, but azoospermia remains common. Semen analysis is mandatory for fertility planning, not optional.
- Estrogen management. Increased intratesticular testosterone aromatizes to estradiol; some men on hCG develop higher estradiol and need monitoring for gynecomastia.
Evidence and limitations
Studies in hypogonadal men and TRT users demonstrate that hCG increases intratesticular testosterone and can restore sperm production in some who were azoospermic on testosterone alone. A systematic approach in reproductive urology uses hCG as a bridge off TRT or as combination therapy, but large randomized trials comparing TRT alone versus TRT plus hCG for long-term outcomes are limited.
hCG does not stimulate FSH-driven Sertoli cell function directly. For men with severely suppressed spermatogenesis, adding recombinant FSH (rFSH) is a specialist-level escalation beyond standard telehealth protocols.
Side effects and monitoring
- Gynecomastia from elevated estradiol
- Acne or mood changes from additional androgen production
- Erythrocytosis additive effect with TRT, CBC monitoring remains essential
- Precocious puberty concerns are irrelevant in adults but dosing must stay within protocol
Baseline and follow-up semen analysis for fertility-focused patients, estradiol, testosterone (trough and peak timing matters less with steady hCG than with cypionate peaks), and hematocrit surveillance mirror standard TRT monitoring with added gonadotropin-specific attention.
hCG vs. enclomiphene vs. TRT alone
Men who have not started TRT and want fertility should consider enclomiphene or hCG monotherapy before committing to exogenous testosterone. Men already on TRT who want children need a supervised transition plan, not casual hCG addition. Men on TRT who want testicular size and partial axis preservation without fertility goals are the clearest hCG adjunct candidates.
CLYR Health offers HCG as a TRT adjunct for appropriate patients under licensed prescriber supervision. It is a tool for specific goals, not a mandatory add-on to every testosterone protocol.